USANA HEALTH SCIENCES, INC. (USNA) Return on equity 2016–2025
USANA HEALTH SCIENCES, INC. (USNA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
2.0%FY2025 · since FY2016: 30.8% → 2.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 2.0% | -5.9 pp |
| FY2024 | 7.9% | -4.9 pp |
| FY2023 | 12.8% | -3.1 pp |
| FY2022 | 16.0% | -13.5 pp |
| FY2021 | 29.5% | +1.3 pp |
| FY2020 | 28.2% | -0.4 pp |
| FY2019 | 28.6% | -3.7 pp |
| FY2018 | 32.3% | +15.1 pp |
| FY2017 | 17.2% | -13.5 pp |
| FY2016 | 30.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More USNA financial trends
USNA RevenueUSNA Net incomeUSNA Net marginUSNA Gross profitUSNA Gross marginUSNA Operating incomeUSNA Operating marginUSNA Operating cash flowUSNA Free cash flowUSNA Capital expendituresUSNA Stock buybacksUSNA Dividends paidUSNA Total assetsUSNA Total liabilitiesUSNA Shareholders’ equityUSNA overview →